May 10, 2019
BioSpecifics Technologies ends quarter with $4.4 million
BioSpecifics reported net income of $4.4 million for the first quarter 2019, compared to net income of $4.0 million, for the same period in 2018.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
May 10, 2019
BioTime Awarded $2.5 Million Grant from the Israel Innovation Authority for Continued Development of OpRegen®
ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank"gt;#AMDlt;/agt;–BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing cellular…
May 10, 2019
Acceleron net loss for the first quartere 2019 $38.1M, R&D expenses $32.8
Acceleron net loss for the first quartere 2019 $38.1M, R&D expenses $32.8
May 10, 2019
Puma Biotechnology finished first quarter 2019 with Non-GAAP adjusted net income of $8.1M
Puma Biotechnology finished first quarter 2019 with Non-GAAP adjusted net income of $8.1M
May 10, 2019
Ocular Therapeutix posts net loss of $17.1 million in the first quarter of 2019
Ocular Therapeutix posts net loss of $17.1 million in the first quarter of 2019
May 10, 2019
Teva launches generic Tarceva (erlotinib) tablets in the United States
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has launched a generic version of Tarceva®1(erlotinib) tablets, 100 and 150 mg, in the U.S.
May 10, 2019
The Medicines Company to Host Investor Conference Call and Webcast During National Lipid Association’s 2019 Scientific Sessions
Company management and clinical trial investigators will review interim results on the long-term safety and efficacy data of inclisiran from…
May 10, 2019
Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma
ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced the Medicare durable medical equipment (DME) Medicare Administrative Contractors (MACs) have issued…
May 10, 2019
The Global Market for Parkinson’s Disease Drugs to 2024 – COMT (Catechol-O-Methyltransferase) Inhibitors to Register Robust Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Parkinson’s Disease Drugs Market – Growth, Trends, and Forecast (2019-2024)” report has been added to ResearchAndMarkets.com’s offering. Parkinson’s…
May 10, 2019
Applied DNA to Webcast 2019 Annual Stockholders’ Meeting
STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN), will hold its 2019 Annual Meeting of Stockholders on Thursday, May…